A million doses of the shot are already being manufactured and will be available by September, even before trials fully prove whether it works.
He also said that one key finding which was particularly reassuring was that there was no evidence of immune-enhanced disease, in which instead of protecting against a virus, a vaccine actually makes the disease worse.
Oxford University has entered into a partnership with UK-based global biopharmaceutical company AstraZeneca for the further development, large-scale manufacture and potential distribution of the vaccine. The team developing the vaccine says once available it will be a low-cost, very, very extensively available vaccine as soon as possible.
Their work has meant that the world's two front-runners to develop a vaccine are right here in the United Kingdom - at the University of Oxford and Imperial College London.
"The UK will be first to get access" to a new vaccine now being trialled, but that ministers will ensure that poorer countries can easily buy it.
"I can announce an Additional £84m of funding to help develop a vaccine".
Prime Minister Boris Johnson, had a similar message in a Mail on Sunday article.
Researchers are screening participants for the trial of Professor Shattock's vaccine, and aim to begin clinical trials in June at the NIHR Imperial Clinical Research Facility. When the monkeys were exposed to the new coronavirus, the vaccine appeared to prevent damage to the lungs and kept the virus from making copies of itself there, although it was still actively replicating in the nose. Researchers running animal trials reported last week that monkeys who received a single jab produced antibodies to the virus within a month.
While the study still needs to be reviewed by other scientists, Dr. Stephen Evans at the London School of Hygiene and Tropical Medicine called the work "high quality" and "very encouraging". "The most important thing is to get the infrastructure in place to vaccinate tens of millions in the population, so it is simply unknown whether opening a vaccine manufacturing facility is the best use of the money".
Speaking at the daily Downing Street press conference, Mr Sharma said that the first clinical trial for a vaccine at the University of Oxford is progressing well.